NP5 fundamentals
NEWRON PHARMACEUT. EO-,20 earnings per share and revenue
Report periodH2 2024
EPS estimate—
Revenue estimate—
H1 '20
H1 '21
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
−0.52
−0.39
−0.26
−0.13
0.00
H1 '21
H1 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
0.00
1.50 M
3.00 M
4.50 M
6.00 M